News from Ƶ Health
While More Is Better, Even Moderate Amounts Of Exercise May Reduce Risk For Common Heart Condition. (Science Daily)
(11/11) Researchers at Ƶ Health conducted a study using Fitbit data from over 6,000 participants, revealing that an additional hour of weekly physical activity reduces the risk of atrial fibrillation by 11%, with those engaging in 2.5 to 5 hours of exercise weekly showing a 60% lower risk; Sean P. Heffron, MD, assistant professor, Department of Medicine, the Leon H. Charney Division of Cardiology, said, “Our findings make clear that you do not need to start running marathons to help prevent atrial fibrillation and other forms of heart disease,” while Souptik Barua, PhD, at NYU Grossman School of Medicine, said, “These results highlight the value of Fitbits and similar monitors in medical research.”
How To Manage Patients On GLP-1s Before Surgery. (MDEdge)
(11/12) Michael A. Weintraub, MD, clinical assistant professor, Department of Medicine, Division of Endocrinology, Diabetes, & Metabolism, discussed the risk of pulmonary aspiration associated with GLP-1 receptor agonists, saying, “The risk of a pulmonary aspiration event with GLP-1 medication is quite rare, but not zero,” and suggested stopping GLP-1 medication a week before procedures to minimize risks while maintaining glycemic control and preventing weight gain, amidst evolving FDA guidance and multi-society recommendations on anesthesia management for patients on these medications.
New Study Reveals Surprising Impact Of Climate Change On Younger Generations: ‘[They’re] Making Choices About The Future.’ (The Cooldown)
(11/12) A study published in The Lancet Planetary Health, led by researchers from institutions including NYU Grossman School of Medicine, surveyed nearly 16,000 Americans aged 16 to 25, revealing that 85% are concerned about climate change’s impact on people and the planet, with significant portions saying it influences their daily functioning, living choices, and decisions on having children.
Finding Function For Noncoding RNAs Using A New Kind Of CRISPR. (Lab Manager Magazine)
(11/12) A study conducted by researchers at New York University and the New York Genome Center reveals that noncoding RNAs have significant functions in human cells, including roles in cancer and development, with Neville Sanjana, PhD, associate professor, Department of Neuroscience and Physiology, saying, “This survey of functional noncoding RNAs advances our understanding of the human genome and demonstrates the potential of CRISPR screens that specifically target RNA – even those that don’t code for proteins.”
Top Hospitals For Stroke Care: Healthgrades. (Becker's Hospital Review)
(11/12) Healthgrades recently “published its 2025 Specialty Excellence Awards recipients,” recognizing 99 hospitals “for delivering superior clinical outcomes in the care and treatment of stroke,” including Ƶ Health.
Is Making Your Bed Bad For You? Experts Debunk Social Media’s Claims. (PopSugar)
(11/11) Tania Mucci-Elliott, MD, clinical instructor, Department of Medicine, Division of Infectious Diseases and Immunology, explained that while dust mites can exacerbate allergies and asthma, making your bed immediately after waking does not significantly impact their presence or health effects, contradicting claims made in a viral video, Dr. Elliott recommended measures such as washing bedding weekly at high temperatures, using dust-mite-proof covers, and controlling bedroom humidity to under 50%.
Continuing Coverage: Ƶ Health Physician Discusses Seasonal Respiratory Viruses. (CBS 4 Valley Central (USA))
(11/12) Jonathan D. LaPook, MD, the Mebane Professor of Gastroenterology, Department of Medicine, Division of Gastroenterology and Hepatology, professor, Department of Population Health, said that with the holiday season approaching, now is the time to get vaccinated against common respiratory viruses, including COVID-19 and the flu, which can be administered simultaneously, and he also recommended wearing a mask in crowded, poorly ventilated spaces.
What To Know About Diabetes: Types, Risk Factors, New Treatments. (TODAY)
(11/12) Natalie E. Azar, MD, clinical associate professor, Department of Medicine, Division of Rheumatology, discussed the types of diabetes, their risk factors, and available treatments, offering tips for managing the disease such as consulting an endocrinologist and engaging in healthy meal planning.
Sales Of Emergency Contraceptives Increase After US Election. (NBC News Now-2)
(11/12) Natalie E. Azar, MD, clinical associate professor, Department of Medicine, Division of Rheumatology, discussed the increased sales of emergency contraceptives following the election, noting that the shelf life of such medications is typically around four years and that while stockpiling is not unsafe, manufacturers may not guarantee effectiveness after that period.
News from Ƶ Hospital—Long Island
Insilico Aces Second Mid-Stage IPF Trial In A Row. (BioSpace)
(11/12) Insilico Medicine reported positive topline results from a Phase IIa trial of its generative AI-developed drug candidate ISM001-055 for idiopathic pulmonary fibrosis, with the trial showing dose-dependent improvements in lung function, including a mean improvement in forced vital capacity at the 60-mg dose, according to the company; Allison B. Reiss, MD, associate professor, Departments of Foundations of Medicine, and Medicine, Ƶ Hospital—Long Island, previously said that current treatments for IPF focus on symptom management and slowing progression, as there is no cure.
Also reporting is (11/12).
